CD8A and colorectal carcinoma: We have demonstrated that NETs drive CRC liver metastasis by remodeling the immune landscape and impeding CD8+ T cell function, and that DNase I-mediated degradation of NETs can reverse this resistance and restore antitumor immunity (181, 182).